Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.
Cell Death Dis. 2023 Nov 20;14(11):757. doi: 10.1038/s41419-023-06156-6.
Cell Death Dis. 2023.
PMID: 37985768
Free PMC article.
Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma.
Zhang D, Zhou Y, Ma Y, Jiang P, Lv H, Liu S, Mu Y, Zhou C, Xiao S, Ji G, Liu P, Zhang N, Sun D, Sun H, Wu N, Jin Y.
Zhang D, et al.
Cell Death Discov. 2022 Aug 17;8(1):365. doi: 10.1038/s41420-022-01153-8.
Cell Death Discov. 2022.
PMID: 35973992
Free PMC article.
Item in Clipboard
Cite
Cite